biotech

Cerus Corporation Announces Proposed Public Offering of Common Stock

Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics on February 28, 2006

cerus_logo.gif

Cerus Corporation announced plans to offer 4,500,000 shares of its common stock in an underwritten public offering.

Cerus' product pipeline include cancer therapy and immunotherapies for infectious diseases, including those that may be used for biodefense (anthrax and tularemia). Cerus also developed the INTERCEPT Blood System, which is designed to enhance the safety of donated blood components by inactivating viruses, bacteria, other pathogens and white blood cells.

For more investor information, refer to Cerus' website.

[Source: Cerus' press release]

Permalink: Cerus Corporation Announces Proposed Public Offering of Common Stock

Tags: stock  investment  biotech  cerus  common  common+stock  public+offering  cerus+corporation 

Vote for Cerus Corporation Announces Proposed Public Offering of Common Stock:

  • Currently 6.50/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 6.50 out of 4 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Tagcloud
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells